Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review
Lucillia Bezu,Dilara Akçal Öksüz,Max Bell,Donal Buggy,Oscar Diaz-Cambronero,Mats Enlund,Patrice Forget,Anil Gupta,Markus W. Hollmann,Daniela Ionescu,Iva Kirac,Daqing Ma,Zhirajr Mokini,Tobias Piegeler,Giuseppe Pranzitelli,Laura Smith,The EuroPeriscope Group The EuroPeriscope Group
DOI: https://doi.org/10.3390/cancers16132304
2024-06-23
Cancers
Abstract:Surgical excision of the primary tumor represents the most frequent and curative procedure for solid malignancies. Compelling evidence suggests that, despite its beneficial effects, surgery may impair immunosurveillance by triggering an immunosuppressive inflammatory stress response and favor recurrence by stimulating minimal residual disease. In addition, many factors interfere with the immune effectors before and after cancer procedures, such as malnutrition, anemia, or subsequent transfusion. Thus, the perioperative period plays a key role in determining oncological outcomes and represents a short phase to circumvent anesthetic and surgical deleterious factors by supporting the immune system through the use of synergistic pharmacological and non-pharmacological approaches. In line with this, accumulating studies indicate that anesthetic agents could drive both protumor or antitumor signaling pathways during or after cancer surgery. While preclinical investigations focusing on anesthetics' impact on the behavior of cancer cells are quite convincing, limited clinical trials studying the consequences on survival and recurrences remain inconclusive. Herein, we highlight the main factors occurring during the perioperative period of cancer surgery and their potential impact on immunomodulation and cancer progression. We also discuss patient management prior to and during surgery, taking into consideration the latest advances in the literature.
oncology